Ding-Jiu H, Run-Fen C, Dao-Sheng Z, Ming-Xin H, Morady F
Department of Cardiology, Ren Ji Hospital, 145 Shang Tung Middle Road, Shanghai, People's Republic of China.
Tex Heart Inst J. 1988;15(1):61-4.
Transvenous catheter ablation techniques have recently been used successfully in blocking posteroseptal accessory pathways in patients with Wolff-Parkinson-White syndrome (WPWS). We report the case of a patient in the People's Republic of China who had WPWS and posteroseptal and right anterolateral accessory pathways, and who had failed to respond to conventional antiarrhythmic drug therapy. The posteroseptal accessory pathway was ablated successfully. During 23 months of follow-up there were no complications; this led us to conclude that this technique can be used to achieve successful long-term ablation of this accessory pathway. This technique obviates the need for drug therapy and direct surgical ablation; it offers, as well, the advantages of shorter hospitalization, lower cost, a much shorter convalescence, and less discomfort to the patient.
经静脉导管消融技术最近已成功用于阻断预激综合征(WPWS)患者的后间隔旁道。我们报告了一名中华人民共和国患者的病例,该患者患有WPWS以及后间隔旁道和右前外侧旁道,并且对传统抗心律失常药物治疗无效。后间隔旁道成功消融。在23个月的随访期间没有并发症;这使我们得出结论,该技术可用于成功长期消融此旁道。该技术无需药物治疗和直接手术消融;它还具有住院时间短、成本低、康复时间短得多以及患者不适感小的优点。